Keyphrases
Thoracic Malignancy
100%
Translational Science
100%
Trial Network
100%
Science Center
100%
Translational Research
71%
Lung Cancer
57%
Research Component
28%
Clinical Trials
28%
Good Science
14%
Resistance to Targeted Agents
14%
Collaborative Team Approach
14%
Lung Cancer Treatment
14%
Molecular Treatment
14%
Genomic Approaches
14%
Overcoming Resistance
14%
Epigenomics
14%
Specific Intent
14%
Proteomic Approach
14%
Tumor Specimens
14%
Improved Outcomes
14%
Molecular Diagnostics
14%
Cancer Tumor
14%
Novel Biomarkers
14%
Risk Stratification
14%
Network Group
14%
Biomarker-driven Clinical Trials
14%
Medicine and Dentistry
Thoracic Cancer
100%
Electrocorticography
100%
Translational Research
55%
Lung Cancer
44%
Clinical Trial
33%
Biological Marker
22%
Proteomics
11%
Risk Stratification
11%
Neoplasm
11%
Immunotherapy
11%
Treatment of Lung Cancer
11%
Malignant Neoplasm
11%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Clinical Trial
60%
Biological Marker
40%
Immunotherapy
20%
Neoplasm
20%
Malignant Neoplasm
20%